annual CFO:
-$109.03M-$17.08M(-18.58%)Summary
- As of today (September 17, 2025), EWTX annual cash flow from operations is -$109.03 million, with the most recent change of -$17.08 million (-18.58%) on December 31, 2024.
- During the last 3 years, EWTX annual CFO has fallen by -$75.52 million (-225.39%).
- EWTX annual CFO is now -1088.83% below its all-time high of -$9.17 million, reached on December 31, 2019.
Performance
EWTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$32.58M+$5.28M(+13.95%)Summary
- As of today (September 17, 2025), EWTX quarterly cash flow from operations is -$32.58 million, with the most recent change of +$5.28 million (+13.95%) on June 30, 2025.
- Over the past year, EWTX quarterly CFO has dropped by -$6.48 million (-24.84%).
- EWTX quarterly CFO is now -1089.56% below its all-time high of -$2.74 million, reached on March 31, 2020.
Performance
EWTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$124.78M-$6.48M(-5.48%)Summary
- As of today (September 17, 2025), EWTX TTM cash flow from operations is -$124.78 million, with the most recent change of -$6.48 million (-5.48%) on June 30, 2025.
- Over the past year, EWTX TTM CFO has dropped by -$21.19 million (-20.46%).
- EWTX TTM CFO is now -4455.64% below its all-time high of -$2.74 million, reached on March 31, 2020.
Performance
EWTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EWTX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.6% | -24.8% | -20.5% |
| 3 y3 years | -225.4% | -100.6% | -168.3% |
| 5 y5 years | -1088.8% | -717.6% | -1755.7% |
EWTX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -225.4% | at low | -174.8% | +13.9% | -168.3% | at low |
| 5 y | 5-year | -1088.8% | at low | -717.6% | +13.9% | -1755.7% | at low |
| alltime | all time | -1088.8% | at low | -1089.6% | +13.9% | -4455.6% | at low |
EWTX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$32.58M(-14.0%) | -$124.78M(+5.5%) |
| Mar 2025 | - | -$37.87M(+40.5%) | -$118.30M(+8.5%) |
| Dec 2024 | -$109.03M(+18.6%) | -$26.96M(-1.5%) | -$109.03M(+0.1%) |
| Sep 2024 | - | -$27.37M(+4.9%) | -$108.90M(+5.1%) |
| Jun 2024 | - | -$26.10M(-8.7%) | -$103.58M(+6.0%) |
| Mar 2024 | - | -$28.60M(+6.6%) | -$97.72M(+6.3%) |
| Dec 2023 | -$91.95M(+74.7%) | -$26.83M(+21.6%) | -$91.95M(+19.5%) |
| Sep 2023 | - | -$22.06M(+9.0%) | -$76.97M(+15.1%) |
| Jun 2023 | - | -$20.23M(-11.4%) | -$66.88M(+6.3%) |
| Mar 2023 | - | -$22.83M(+92.5%) | -$62.89M(+19.5%) |
| Dec 2022 | -$52.63M | -$11.86M(-0.9%) | -$52.63M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$11.96M(-26.4%) | -$50.20M(+8.0%) |
| Jun 2022 | - | -$16.25M(+29.2%) | -$46.50M(+16.2%) |
| Mar 2022 | - | -$12.57M(+33.5%) | -$40.02M(+19.4%) |
| Dec 2021 | -$33.51M(+129.0%) | -$9.42M(+14.0%) | -$33.51M(+16.6%) |
| Sep 2021 | - | -$8.26M(-15.4%) | -$28.73M(+40.4%) |
| Jun 2021 | - | -$9.77M(+61.3%) | -$20.46M(+39.4%) |
| Mar 2021 | - | -$6.06M(+30.6%) | -$14.68M(+29.2%) |
| Dec 2020 | -$14.63M(+59.6%) | -$4.64M(+16.4%) | -$11.36M(+69.0%) |
| Jun 2020 | - | -$3.98M(+45.5%) | -$6.72M(+145.5%) |
| Mar 2020 | - | -$2.74M | -$2.74M |
| Dec 2019 | -$9.17M | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual CFO year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM CFO year-on-year change?
What is Edgewise Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of EWTX is -$109.03M
What is the all time high annual CFO for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual cash flow from operations is -$9.17M
What is Edgewise Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, EWTX annual cash flow from operations has changed by -$17.08M (-18.58%)
What is Edgewise Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of EWTX is -$32.58M
What is the all time high quarterly CFO for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly cash flow from operations is -$2.74M
What is Edgewise Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, EWTX quarterly cash flow from operations has changed by -$6.48M (-24.84%)
What is Edgewise Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of EWTX is -$124.78M
What is the all time high TTM CFO for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM cash flow from operations is -$2.74M
What is Edgewise Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, EWTX TTM cash flow from operations has changed by -$21.19M (-20.46%)